CONTACT US   SITE MAP   SEARCH


 
 
Investor Relations Home
Investor Events
Featured Reports
DateTitle
06/29/10
Download Documentation 2008 Annual Report
05/01/09
Download Documentation 2009 SuperGen Proxy
04/27/09
Download Documentation 2008 Annual Report
Get help downloading or viewing the above file types
Corporate Profile
SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer.

The company possesses a broad portfolio of proprietary cancer therapies that target a variety of solid tumors, hematological malignancies and blood disorders, offering renewed hope to patients who suffer from these illness... More >>

Stock Quote
SUPG (common stock)
ExchangeNASDAQ GM (US Dollar)
Price$2.06
Change (%) Stock is Up 0.03 (1.48%)
Volume142,807
Data as of 09/03/10 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
Date Title
08/02/10Printer Friendly VersionSuperGen Reports 2010 Second Quarter Financial Results
07/26/10Printer Friendly VersionSuperGen to Announce 2010 Second Quarter Financial Results on August 2, 2010
06/30/10Printer Friendly VersionDacogen(R) (Decitabine) for Injection Phase III AML Results Announced
06/02/10Printer Friendly VersionSuperGen to Present in New York on June 8 and 9
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

Privacy Policy
Terms/Conditions
Copyright © Supergen